(Q33364244)

English

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

scientific article

Statements

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma (English)
Craig Moskowitz
Barbara MacGregor-Cortelli
Michael Stubblefield
David Straus
Carol Portlock
Elizabeth Choi
Otila Dumetrescu
Dixie Esseltine
Elizabeth Trehu
Julian Adams
David Schenkein
21 December 2004

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit